Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 14/20 | 0.61 |
| ▸ | MAOA | P21397 | 8/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.49 |
| ▸ | CA4 | P22748 | 3/20 | 0.49 |
| ▸ | CA9 | Q16790 | 3/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22016810 | 0.82 | MAOB (0.44) | MAOBMAOAKDM4EALDH1A1GLA | |
| SCHEMBL29331103 | 0.77 | MAPT (0.47) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL29254676 | 0.74 | MEN1 (0.48) | KDM4EALDH1A1GAAHPGD | |
| SCHEMBL27404104 | 0.73 | MAOA (0.48) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL11502238 | 0.73 | MAOB (0.66) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL11502161 | 0.72 | MAOB (0.76) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL22017341 | 0.71 | CA12 (0.66) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL11502126 | 0.70 | MAOB (0.79) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL29331064 | 0.70 | GSTP1 (0.44) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL11396698 | 0.68 | ALDH1A1 (0.78) | MAOBMAOACA12CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129909-B2 | Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2021-09-28 | — | — | US | disclosed |
| US-20200155707-A1 | CONJUGATE AND BLOCK COPOLYMER CONTAINING FLUORESCENT CHROMOPHORE AND PREPARATION METHOD THEREFOR AND USE THEREOF | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129909-B2 | Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof | WEE1, FAR1, FURIN | MAOB 1529/4885MAOA 2560/4885CA12 252/4885 |
| US-20200155707-A1 | CONJUGATE AND BLOCK COPOLYMER CONTAINING FLUORESCENT CHROMOPHORE AND PREPARATION METHOD THEREFOR AND USE THEREOF | WEE1, FAR1, FURIN | MAOB 1529/4885MAOA 2560/4885CA12 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.